Robert Baltera

Robert F.
Baltera is the founder of Hawkeye Therapeutics, Inc., founded in 2016, serving as Chief Executive Officer.
Mr. Baltera was the founder of Mavupharma, Inc., founded in 2017, serving as Executive Chairman from 2017 to 2019.
Mr. Baltera is the founder of Trestle Biotherapeutics, Inc., founded in 2020, serving as Executive Chairman since 2020.
Current jobs include Executive Chairman at Adheron Therapeutics, Inc., Director at Panmira Pharmaceuticals LLC, Director at Inipharm, Inc. since 2020, Director at FLAP LLC, Independent Director at Palisade Bio, Inc. starting 2026, and Senior Advisor at Frazier Management LLC since 2022.
Former jobs include Chief Executive Officer & Director at Laguna Pharmaceuticals, Inc. in 2015, Chief Executive Officer at Amira Pharmaceuticals, Inc. from 2007 to 2011, Chief Executive Officer & Director at Cirius Therapeutics, Inc., Director at Aravive Biologics, Inc., Director at Organovo, Inc., Independent Director at Frazier Lifesciences Acquisition Corp., Independent Director at Imago BioSciences, Inc. from 2020 to 2023, Independent Director at VivoSim Labs, Inc. from 2016 to 2019, Independent Director at Xencor, Inc. from 2013 to 2017, Director at Arcturus Therapeutics, Inc., Director at San Diego Venture Group, Vice President-Corporate & Contract Manufacturing at Amgen, Inc., and Trustee at Keck Graduate Institute of Applied Life Sciences.
Education includes undergraduate degree in 1987 and graduate degree in 1990 from The Pennsylvania State University, and an MBAistration degree in 1996 from UCLA Anderson School of Management.